chrisvoncsefalvay/vaers-outcomes huggingface dataset:
body aches; CHILLS; LOW GRADE FEVER; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on MAR-2021 for prophylactic vaccination.The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced body aches. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced low grade fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, chills, and low grade fever. This report was non-serious.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 032L20A.) for COVID-19 vaccination.     The patient's past medical history included Surgery (Abdominal surgery) on 19-Aug-2021. Previously administered products included for Influenza immunisation: flu shot (Patient was reported to take the flu shot after the abdominal surgery).   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever). On 26-Feb-2021, PYREXIA (Fever) had resolved.            No concomitant medications were reported.  No treatment information was reported.
pt recv vax 6NOV96 & 20NOV96 pt exp fever for 1 noc, cough, rash, feeling sleepy, & not eating well;
Headache; Malaise; Fatigue; Gastrointestinal symptoms; Shivering; Fever; This case was reported by a consumer via call center representative and described the occurrence of headache in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th September 2021, the patient received the 1st dose of Shingrix. On 15th September 2021, immediately after receiving Shingrix, the patient experienced headache, malaise, fatigue, gastrointestinal symptom nos, shivering and fever. On an unknown date, the outcome of the headache, malaise, fatigue, gastrointestinal symptom nos, shivering and fever were unknown.   It was unknown if the reporter considered the headache, malaise, fatigue, gastrointestinal symptom nos, shivering and fever to be related to Shingrix.  Additional details were reported as follows: This case reported by the father in law of patient. The age at vaccination was not reported. The reporter stated that, the patient received Shingrix vaccine last Wednesday and immediately began experiencing all listed side effects , including headache, malaise, fever, shivering, fatigue, and gastrointestinal symptoms. The reporter did not provide details regarding whether symptoms have resolved. The reporter did not consent to follow-up. The reporter declined to provide demographics for son in law/patient.
Couple of deaths occurred after Pfizer vaccine, some of them immediately, some in few hour/5 death happen and some after the 2nd vaccine and one of them immediately after vaccine; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 5 patients, this is the 5th report.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient died on an unspecified date. Reporter wanted to ask about the question about moving the vaccine in packets of ice for like 2or 3 or 4 hour. Will it make it less effective or may be bad effect? Reporter stated, the question was about couple of deaths occurred after Pfizer vaccine, some of them immediately, some in few hour. Their question was about the vaccine that was carried by just ice for like 5 hour, may be this was the problem. Reporter stated, everything is fine you know in one village with 2000 population, 5 death happen and some after the 2nd vaccine and one of them immediately after vaccine. The vaccine was kept in ice box for like 5 hours, other village it just about 3, another village or 2. The question is, if the ice box is enough for carrying the vaccine. It was not reported if an autopsy was performed. Seriousness criteria was resulted in death.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100944572 same reporter/drug/event, different patient; Reported Cause(s) of Death: Couple of deaths occurred after Pfizer vaccine, some of them immediately, some in few hour/5 death happen and some after the 2nd vaccine and one of them immediately after vaccine
Very bad muscle aches; Fatigue; headache; Fever of 102; Sweats; Uncontrollable chills; This is a spontaneous report received from a contactable consumer, the patient. A 60-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: Unknown, Dose number: 2) via an unspecified route of administration in the left arm on 10Mar2021 at 10:30 AM (age unknown at the time of vaccination) as a single dose for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient medical history and concomitant medications were not reported. The patient past drug history included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: Unknown, Dose number: 1) via an unspecified route of administration in the left arm on 17Feb2021 10:30 AM as a single dose for COVID-19 immunization. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Approximately 10 hours after the second dose on 10Mar2021 patient started having uncontrollable chills and fever of 102. A couple of hours after the chills had subsided, but she started having headache and very bad muscle aches. It continued all night into the morning. Therapeutic measures included Advil for headache and muscle aches. The muscle aches, fatigue and low-grade fever continued for 4 days after the second dose. Patient still continued to struggle with fatigue and started having sweats. The clinical outcome of the events sweating and fatigue was not resolved and for the events muscle ache, headache, fever and chills were resolved on 14Mar2021 (reported as 4 days after second dose). Information about lot/batch number cannot be obtained. No further information is expected.
Site very painful and irritated several days after vaccine administered. Called MD and reported 12/16/16 they want Pt to come in. (Pt out of town-will call MD).
94 year old female brought into the clinic today by her son. He has concerns that she has been sick since last week. She lives by herself and usually ambulates with the use of a cane. She was in bed all day on Saturday and has been extremely weak.  He states that she has had chills and has been having trouble with getting out of a chair because of weakness.  She has a mild cough and runny nose. She has had some frequency of urination. She has a problem with constipation and does not remember when she had her last BM. The patient has dementia.
Patient given #2 dose Hep A at 2 months instead of 6 months.
Patient was vaccinated for COVID-19 on 4/3/21 and 4/24/21, so was fully vaccinated when testing positive for COVID-19 on 10/8/21.
Headache, Myalgia, Arthralgia & Fever Narrative: patients is too sick to come into work
Measles-like rash (skin eruption). Generalized full-body, non-pruritic; began to notice 2 days after vaccine administration. Today, 5 days later, continue to find new eruptions. COVID-19 arm; largest at 2 cm; indurated and mild pain at 3 days post vaccination.
Information has been received from a registered pharmacist (R. Ph) concerning a 67 year old female patient who on 06-APR-2011, was vaccinated with a dose of ZOSTAVAX (Merck) (lot number and site of administration not reported). On 06-APR-2011, the patient experienced redness at the injection site. No treatment was given for the adverse event. The patient did not seek medical attention. At the time of the report, the patient had recovered from redness at the injection site on an unspecified date. Additional information has been requested.
Extreme soreness in arm that received vaccination. Soreness extended through entire arm, armpit, breast, and side body
Itching occurred less than an hour after the vaccine had been administered. I took one diphenhydramine 25mg tablet when I got home about 1500 on 9/30. I took another diphenhydramine tablet about 2100 on 9/30. Woke up on 10/1 it was very red, itchy, raised, and hurt to touch. Took my normal antihistamines I take for allergies (allegra in the morning, xyzal at night) still was itching bought diphenydramine cream at the store applied it. I took diphenydramine 50mg that night. Monday morning, the blotchiness and redness had not decreased, my arm was hurting all the way into my armpit around my lymph node. I am a clinical pharmacist in a hospital, had a physician look at it and he suggested having my PCP look at it. She looked at it and prescribed 20mg prednisone x5 days. After taking the first dose of prednisone the redness, itching, and size has decreased.
LUA at injection site is painful/swollen/hot and increasing in size - patient seen in office dx with cellulitis - patient put on a oral abo.
11-year-old patient received a dose of Infanrix; received Infanrix instead of a Boostrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old male patient who received DTPa (Infanrix) (batch number LS444, expiry date 16th September 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 29th March 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 29th March 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 29-Mar-2022 Reporter's Comments: Medical assistant reported that the patient received a dose of Infanrix instead of a Boostrix. The consent to follow up was given. Additional Supportive Information: The patient received Infanrix instead of Boostrix, which led to inappropriate age at vaccine administration and wrong vaccine administered.
Tested positive today for COVID19 says "maybe it is a false positive" patient declines having symptoms; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive today for COVID19 says "maybe it is a false positive" patient declines having symptoms) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.    The patient's past medical history included COVID-19 (Patient had COVID 19 in Nov 2020 and has tested negative later) in November 2020 and Surgery (Carpal tunnel surgery).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jul-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive today for COVID19 says "maybe it is a false positive" patient declines having symptoms).      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient is taking some prescribed medications details were not provided. Patient was supposed to have elbow replacement surgery.
I got the flu shot around 10:00 at employee health. Around 12:00 I noticed I was feeling tired and my heart was racing. I took my pulse it was 100 which I usually run around 70. Then I just started feeling nausea and my back started hurting. Anyhow at 5 I had to go to this class for my job. During the class I started sweating and tingling all over and felt like I was going to vomit or pass out so I got up and went down to clinic and laid down on the floor. The other nurses I work with took my vitals my BP was normal but my pulse was 116. I felt like my back hurt so bad and my chest and I felt like I couldn't breathe. So I just laid there with the lights off for like 20 min. but everytime I tried to sit up I got all sweaty again. So one of the other nurses I work with drove me home. I was very sick that night, I had a pounding heading. My lower back hurt so bad. I felt like I could breathe my chest felt tight. The next day I had to call into work. I couldn't eat anything. My head still hurt but was better. I was extremely fatigued I just laid on the couch the whole day. It was horrible. I will never ever get another flu shot for the rest of my life!
I had Covid in November and was told that there was a high probability that I would get sick but was not prepared for this.  It is like I am sick all over.  Fever, no taste (It all reminds me of cardboard), exhausted, sleeping, no appetite, mild nausea, headache, winded easily
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE DEMAND ISCHEMIA ACUTE RESPIRATORY FAILURE
Information has been received from a nurse referring to a patient of unknown age and gender. Information about medical history and concurrent conditions were unspecified. On 22-DEC-2015, less than the recommended dose of ROTATEQ (lot number, expiration date and dose unknown) was administered to the patient orally. Concomitant medications were unspecified. Then the patient proceeded to vomit on the same day. The outcome of the events was unknown. The causality between vomiting and oral, ROTATEQ was unspecified. Additional information has been requested.
Stomach Ache within 6 hours - unusually tired slept for 12 hours. Next day heachage and onset of high (104.9) fever at 32 hours post vaccination with vomiting. High fever (104++)with severe headache lasted 24+ hours.
Shortly after the vaccine was administered I began to have discomfort at the vaccination site. It would cycle through five to ten minutes each of severe itching, then burning, then soreness. This went on for a couple of hours. Later it was just sore. I've never previously had any reaction to a flu vaccine.  I had the pneumonia vaccine at the same time. That vaccination site became raised and red in the diameter of about a half dollar. There was also a bright red streak bout three inches long and about a half inch wide extending from the vaccination site over my shoulder towards the breast. The site and line were very sore.
Soreness at the injection site; Felt nauseous; Very lightheaded and needed help to lie down; Had the chills for several hours; Slept and woke up sweating; Feeling hot; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Oct2022 at 10:00 as dose 3 (booster), single (Lot number: GJ3277) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "IBS" (unspecified if ongoing); "Migraines" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE; LOSARTAN; ATORVASTATIN; HCL PLUS. Vaccination history included: covid19 vaccine (Dose 2, Lot number: FM7553, Time of administration: 01:00 PM, vaccine location: Left arm), administration date: 21May2022, when the patient was 64-year-old, for COVID-19 immunization; covid19 vaccine (Dose 1, Lot number: 1855194, Time of administration: 09:30 PM, vaccine location: Left arm), administration date: 11Nov2021, when the patient was 63-year-old, for COVID-19 immunization. The following information was reported: FEELING HOT (non-serious) with onset 21Oct2022 at 18:00, outcome "recovered" (22Oct2022); NAUSEA (non-serious) with onset 21Oct2022 at 18:00, outcome "recovered" (22Oct2022), described as "Felt nauseous"; CHILLS (non-serious) with onset 21Oct2022 at 18:00, outcome "recovered" (22Oct2022), described as "Had the chills for several hours"; HYPERHIDROSIS (non-serious) with onset 21Oct2022 at 18:00, outcome "recovered" (22Oct2022), described as "Slept and woke up sweating"; VACCINATION SITE PAIN (non-serious) with onset 21Oct2022 at 18:00, outcome "recovered" (22Oct2022), described as "Soreness at the injection site"; DIZZINESS (non-serious) with onset 21Oct2022 at 18:00, outcome "recovered" (22Oct2022), described as "Very lightheaded and needed help to lie down". Therapeutic measures were not taken as a result of vaccination site pain, nausea, dizziness, chills, hyperhidrosis, feeling hot.  Additional information: Facility type vaccine was Pharmacy or Drug Store. Patient had no known allergy. Patient had no other vaccine in four weeks. Adverse events were reported as soreness at the injection site, then about 8 hours later felt nauseous, very lightheaded and needed help to lie down. Had the chills for several hours. Slept and woke up sweating and feeling hot. All symptoms had disappeared by the following morning and after about 24 hours.
7JAN91 received message to contact MD about possible meningitis case. 8JAN91 follow-up call was told to "get our lawyers." No other information.
muscle pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (muscle pain) and FATIGUE (fatigue). At the time of the report, MYALGIA (muscle pain) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details reported.
Blurry vision  Burning/painful eyes Watery eyes Pain/Numbness throughout entire arm/hand of arm used Cold painful fingers of hand on arm used Limited range of motion on arm used  Bruising at injection site
Administered vaccine and got up to leave and within 3 minutes patient passed out.  Patient also, demonstrated tremors with eyes rolling back.  The patient's mother was there and is a physician's assistant.  The patient then snapped out of it and was talking to mom.  Patient tried to stand up after laying for a while and then passed out again..  911 was called and an ambulance took patient to hospital for observation.
Pt received the vaccine with no side effects for approximately 36 hours. He woke up on the second day after the vaccination with intense pain in his knee. He was unable to bend the knee and was barely able to walk.
Patient received pediatric dose of pfizer instead of Purple Top 12+ pfizer- (0.3)ml Vitals were taken BP:139/85, 02:00 PULS:89 RES:18. Pt was observed for 30 mins. Parent was educated about the vaccine received by the nurse. Pt had no complaints of nausea, head or vomiting.
patient came in for 4th shot of Pfizer 6/12/22 and today she has a swollen red arm that is hot to the touch, pain is radiating under armpit
Symptoms - cough, congestion, fatigue, fever, and body aches on 3/5/22
Gastritis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Feb2021 (Batch/Lot number: unknown) as dose 2 , single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (COVID Vaccine Dose-1), administration date: Jan2021, for COVID-19 immunisation. The following information was reported: GASTRITIS (non-serious) with onset Mar2021, outcome "unknown", described as "Gastritis".  Additional Information: Caller was a consumer that was calling about the Pfizer Covid-19 vaccine and said that she took the first dose in Jan2021 and the second dose in Feb2021. Caller said that she took the booster in Sep2021. Caller reported that she developed Gastritis in Mar2021 and would like to know if this had anything to do with the Covid-19 vaccine or has this been reported with the vaccine. Caller said that she read something online about it and heard something about it.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Information has been received from the physician concerning a 19 year old female patient who prior to 2008 was vaccinated with three doses of GARDASIL (Lots# not reported). On 29-JAN-2010 the patient experienced LGSIL (Low Grade Squamous Intraepitheliel Lesion) and HR (high risk) HPV PAP. At the time of this report, the patient's outcome was unknown. This is one of the reports received from same source. Additional information has been requested.
Developed a rash in her vaccinated arm; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient reported for herself that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown, and Expiration date: Unknown) via an unspecified route of administration on an unspecified date in May2021 as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient got her first dose of the vaccine mid of May2021 and was set to get her 2nd dose this weekend, but she developed a rash in her vaccinated arm on an unspecified date. The patient wanted to know if there were reports regarding delayed rash reactions in the vaccinated arm 2-3 weeks after getting the first dose of the Pfizer BioNTech COVID-19 Vaccine. She also wanted to know if it would be safe to take the second dose while experiencing rash. The outcome of the event was unknown.  Follow up attempts are needed. Information on lot/batch number is requested.
I received my vaccine at 3 PM on 4/8/21. The next morning I was awakened at about 5 AM by a very loud pulsating in my left ear. I was unable to continue sleep. This pulsating in left ear has continued non stop since then. Today is 4/11/21. I have reported this by email to my primary care physician , but still waiting for response.